References
- Omura S, Tsuyuki Y, Ohta S, et al. Rapid tumour necrosis induced by electrochemotherapy with intratumoral injection of bleomycin in a hamster tongue cancer model. Int J Oral Maxillofac Surg. 2000;29(2):119–125.
- Rabussay DP, Nanda GS, Goldfarb PM. Enhancing the effectiveness of drug-based cancer therapy by electroporation (electropermeabilization). Technol Cancer Res Treat. 2002;1(1):71–82.
- Wichtowski M, Murawa D, Czarnecki R, et al. Electrochemotherapy in the treatment of breast cancer metastasis to the skin and subcutaneous tissue - multicenter experience. Oncol Res Treat. 2019;42(1–2):47–51.
- Bertino G, Sersa G, De Terlizzi F, et al. European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: results of the treatment of skin cancer. Eur J Cancer. 2016;63:41–52.
- Allegra E, Domanico R, Trapasso S, et al. Electrochemotherapy in combination with chemoradiotherapy in the treatment of oral carcinomas in advanced stages of disease: efficacy, safety, and clinical outcomes in a small number of selected cases. Drug Des Devel Ther. 2015;9:1185–1191.
- Plaschke CC, Johannesen HH, Hansen RH, et al. The DAHANCA 32 study: electrochemotherapy for recurrent mucosal head and neck cancer. Head Neck. 2019;41(2):329–339.
- Bloom DC, Goldfarb PM. The role of intratumour therapy with electroporation and bleomycin in the management of advanced squamous cell carcinoma of the head and neck. Eur J Surg Oncol. 2005;31(9):1029–1035.
- Tijink BM, De Bree R, Dongen G, et al. How we do it: Chemo-electroporation in the head and neck for otherwise untreatable patients. Clin Otolaryngol. 2006;31(5):447–451.
- Heller R, Jaroszeski MJ, Reintgen DS, et al. Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer. 1998;83(1):148–157.
- Burian M, Formanek M, Regele H. Electroporation therapy in head and neck cancer. Acta Otolaryngol. 2003;123(2):264–268.
- Landström FJ, Nilsson COS, Reizenstein JA, et al. Electroporation therapy for T1 and T2 oral tongue cancer. Acta Otolaryngol. 2011;131(6):660–664.
- Gargiulo M, Papa A, Capasso P, et al. Electrochemotherapy for non-melanoma head and neck cancers. Clinical outcomes in 25 patients. Ann Surg. 2012;255(6):1158–1164.
- Landström FJ, Reizenstein J, Adamsson GB, et al. Long-term follow-up in patients treated with curative electrochemotherapy for cancer in the oral cavity and oropharynx. Acta Otolaryngol. 2015;135(10):1070–1078.
- Ganly I, Goldstein D, Carlson DL, et al. Long-term regional control and survival in patients with “low-risk,” early stage oral tongue cancer managed by partial glossectomy and neck dissection without postoperative radiation: the importance of tumor thickness. Cancer. 2013;119(6):1168–1176.
- Oliveira MLC, Wagner VP, Sant'Ana Filho M, et al. A 10-year analysis of the oral squamous cell carcinoma profile in patients from public health centers in Uruguay. Braz Oral Res. 2015;29(1):1–8.
- Ord RA, Isaiah A, Dyalram D, et al. Is long-term follow-up mandatory for stage I oral tongue cancer? J Oral Maxillofac Surg. 2018;76(12):2676–2683.
- Jarm T, Cemazar M, Miklavcic D, et al. Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases. Expert Rev Anticancer Ther. 2010;10(5):729–746.
- Gothelf A, Mir LM, Gehl J. Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat Rev. 2003;29(5):371–387.
- Quaglino P, Matthiessen LW, Curatolo P, et al. Predicting patients at risk for pain associated with electrochemotherapy. Acta Oncol. 2015;54(3):298–306.
- Macri GF, Greco A, Gallo A, et al. Use of electrochemotherapy in a case of neck skin metastasis of oral squamous cell carcinoma: Case report and considerations. Head Neck. 2014;36(9):E86–90.